Pharma Manufacturer Federal Government Price Reporting: Recent Litigation and Settlements | Goodwin
Litigation involving drug price reporting under the Medicaid Drug Rebate Program (MDRP)1 has been very active in 2022. Most recently, on August 3, 2022, an Illinois...

